Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Part of paid clinical trials in Macon, Georgia.
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Study ID
- NCT00639769
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cisplatin — DRUGStarting dose 30 mg/m2 Dose level -1 20 mg/m2
- irinotecan hydrochloride — DRUG50 mg/m2 IV over 60 minutes, plus Cisplatin 30mig/m2 IV, repeated weekly for two weeks. followed by a one-week rest. This 3-week schedule given two times to equal one 6-week cycle. Maximum of 6 cycles.
Study Details
RATIONALE: Drugs used in chemotherapy, such as irinotecan and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: To determine if CPT-11 given together with cisplatin is effective in treating recurrent or metastatic head and neck cancer.
Key Dates
- Start date
- Feb 28, 2002
- Status verified
- Sep 2012
- Primary completion
- May 31, 2007
- Completion
- Jul 31, 2008
Study Design
- Enrollment
- 41 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Therapeutic Intervention
Primary Outcome Measure
Patient Response [ Time Frame: 6 weeks after last chemotherapy treatment ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Central Georgia Hematology Oncology Associates, P.C. | Macon | Georgia | - | - |
| Erlanger Health System | Chattanooga | Tennessee | - | - |
| Jackson-Madison County Hospital | Jackson | Tennessee | - | - |
| East Tennessee State University | Johnson City | Tennessee | - | - |
| Center for Biomedical Research | Knoxville | Tennessee | - | - |
| Meharry Medical College | Nashville | Tennessee | - | - |
| VA Tennessee Valley Healthcare Center | Nashville | Tennessee | - | - |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | - | - |
Find similar trials in Macon, GA
By condition
Related Studies
- Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck CancerPHASE2 · Recruiting · National Institute on Deafness and Other Communication Disorders (NIDCD) · Atlanta, Georgia
- Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck CancerPHASE1/PHASE2 · Recruiting · Natalie Lockney · Nashville, Tennessee